22h
Fatty liver often stays silent until it's too late. Here's why doctors say you shouldn't ignore it
Fatty liver often has no symptoms until significant damage occurs. Doctors explain who is at risk, early warning signs, how ...
A new startup is making a bold move in the world of obesity drug development: It’s not working with the GLP-1 target that has ...
Wide-scale NHS cuts have 'disproportionately' affected staff supporting children with special educational needs ...
To a large extent, I’m on board with the body positivity movement, but there’s no escaping the fact that the best way to ...
India plans to replace BMI with waist-to-hip ratio in public hospitals, with nearly 1 million ASHA workers helping identify ...
In industrialized countries, the gaps in systolic BP and cholesterol have shrunk between obese and normal-weight individuals.
An international study reveals a slowdown in obesity growth among affluent countries, while Estonia grapples with rising ...
Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced ...
THEY are arguably the biggest medical breakthrough of recent times, helping Brits to shed the pounds with barely any effort ...
IN THE SPACE of less than a decade, medicine acquired a means of doing what millennia of diets and exhortation could not. A ...
10dOpinion
How GLP-1s Feed Our Sick Culture
Her uncomfortable candor is a useful illustration of how the widespread availability of GLP-1s has further warped the way ...
Obesity rates among U.S. adults and children rose sharply in recent years, and by 2023, 40% of adults and 20% of youth met ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results